NCT02116816

Brief Summary

This study consists of two parts. The first part of the study looked at the absorption of three different polyphenol preparations into the blood, the variability of their absorption and whether their absorption could be enhanced by mixing with pollen shells. For this purpose 12 healthy volunteers were recruited. All participants received all the 3 supplements with and without mixing with pollen shells so they had a total of 3 tests. For each test six blood samples were taken over an 8 hour period. Urine samples were also collected. Oligopin was selected from the first study. The second part of study aims to look at the effects of Oligopin on endothelial function by assessing vascular tone and function in healthy volunteers using a non-invasive, direct measurement of vasodilatory capacity (EndoPAT). Nitrate and nitrite measurements, as well as blood pressure measurements, will also be recorded to provide a clear clinical assessment of the effects of this preparation (if any) upon vascular function. The effects of Oligopin will be compared to a placebo (methylcellulose-filled capsules) to allow a robust assessment of any clinical effects. A total of 24 healthy volunteers will be recruited for this study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2014

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

April 15, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 17, 2014

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2015

Completed
Last Updated

July 16, 2019

Status Verified

July 1, 2019

Enrollment Period

1.1 years

First QC Date

April 15, 2014

Last Update Submit

July 12, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Area Under the Absorption Curve for each polyphenol preparation

    Blood samples will be withdrawn 6 times over an 8 hour period: baseline, then 30 minutes, 1 hour, 2 hours, 4 hours and 8 hours after ingestion of each polyphenol supplement (total 3 supplements)

    8 hours

Study Arms (1)

Polyphenol

EXPERIMENTAL

Polyphenol preparations

Dietary Supplement: Polyphenol

Interventions

PolyphenolDIETARY_SUPPLEMENT

Polyphenol

Polyphenol

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or Female subjects between the age of 18-65 who can speak and understand English
  • No concomitant medication including herbal medicines and food supplements
  • No concomitant disease processes
  • Body Mass Index 21- 29kg/m2
  • Systolic blood pressure ≤150 mm Hg and diastolic pressure \<90 mm Hg
  • Subjects who have given informed consent

You may not qualify if:

  • Patients not wishing to allow disclosure to their GPs.
  • Concomitant medication including herbal medicines and food supplements
  • Concomitant disease processes
  • History of drug/alcohol abuse or Alcohol intake within 24 hours of dosing visit (visits 2-4)
  • Body Mass Index \<21 and \> 29kg/m2
  • Systolic blood pressure \>150 mm Hg and or a diastolic pressure\>90 mm Hg
  • Unable to tolerate polyphenol products or adhere to low polyphenol diet
  • Vegetarian
  • Subjects not willing or able to fast until 12 noon (a total of 14 hours).
  • Pregnant females or planning to conceive in the next 3 months.
  • Participation in any other study currently or in the last three months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Michael White Centre for Diabetes and Endocrinology

Hull, East Yorkshire, HU3 2RW, United Kingdom

Location

MeSH Terms

Interventions

Polyphenols

Intervention Hierarchy (Ancestors)

PhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic Chemicals

Study Officials

  • Thozhukat Sathyapalan, MBBS FRCP MD

    University of Hull

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 15, 2014

First Posted

April 17, 2014

Study Start

April 1, 2014

Primary Completion

May 1, 2015

Study Completion

May 1, 2015

Last Updated

July 16, 2019

Record last verified: 2019-07

Locations